Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patientsWOLTERS, R; WÖCKEL, A; JANNI, W et al.Breast cancer research and treatment. 2013, Vol 142, Num 3, pp 579-590, issn 0167-6806, 12 p.Article

The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjectsWÖCKEL, A; WOLTERS, R; WIEGEL, T et al.Annals of oncology. 2014, Vol 25, Num 3, pp 628-632, issn 0923-7534, 5 p.Article

Assessing the impact of CMF-like/Anthracycline-based/Anthracycline-Taxane-based/dose-dense chemotherapy in dependency of positive axillary lymph nodes/hormone receptor-status/grading/T-stage on survival - A retrospective multi-centre cohort study of 3677 patients receiving adjuvant chemotherapySCHWENTNER, L; WÖCKEL, A; KÖNIG, J et al.European journal of cancer (1990). 2014, Vol 50, Num 17, pp 2905-2915, issn 0959-8049, 11 p.Article

Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzleWOLTERS, R; SCHWENTNER, L; REGIERER, A et al.Breast cancer research and treatment. 2012, Vol 131, Num 3, pp 925-931, issn 0167-6806, 7 p.Article

Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival—a retrospective multi-centre cohort studySCHWENTNER, L; WOLTERS, R; KORETZ, K et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 1073-1080, issn 0167-6806, 8 p.Article